Gravity liquid pump can handle sensitive data
Degassing specialist Biotech Fluidics has launched the foundation of Ventri Labs AB (VentriLabs).
This is a new subsidiary set-up to leverage the disruptive benefits of its patented gravity liquid pump technology for handling of sensitive media.
Use of conventional mechanical pumps is known to negatively affect sensitive biological materials limiting their use in bioprocessing, clinical and tissue engineering applications. The product was engineered to ensure delicate handling of sensitive media.
The VentriLabs´ gravity-based pump technology reduces destructive mechanical and shearing effects by up to 95% while pumping blood, as compared with commonly used peristaltic pumps, according to the company.
This technology is also highly controllable, eliminating pulsation effects inherent in peristaltic and membrane pumps. In filtration applications this equates to improved efficiency and yields that translate into a more cost-efficient process for the user.
Dr Robin Öz, CEO of VentriLabs said: “having committed multi-year funding from our parent company and a strong intellectual property portfolio – we are inviting collaborative partners and investors to accelerate the process, and further development of our groundbreaking liquid pump technology in lab, process and clinical applications.”
